Schedule 13G ownership disclosure

Actuate Therapeutics Inc

Common Stock, par value $0.0001 per share · CUSIP: 005083100

Event date: 2025-12-15

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Voss Capital, LP

    Shares: 1,227,756.00 · Class: 5.3%

  • Cocke Travis W.

    Shares: 1,227,756.00 · Class: 5.3%

  • Voss Advisors GP, LLC

    Shares: 250,000.00 · Class: 1.1%

  • Voss Value Master Fund, LP

    Shares: 200,000.00 · Class: 0.9%

  • Voss Value-Oriented Special Situations Fund, LP

    Shares: 50,000.00 · Class: 0.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001730145-25-000035
Form type
SCHEDULE 13G
Filer
ACTUATE THERAPEUTICS, INC.
CIK
CIK 1652935
Filed
Dec 17, 2025
Reporting period
Dec 15, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub